Please assess the completion status of the following clinical trial:

Trial Title: tDCS & Auditory Hallucinations in Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 18-60~* Primary diagnosis of Diagnostic and Statistical Manual, fifth edition, schizophrenia~* Persistent auditory verbal hallucinations~* Right handed~* Under stable doses of antipsychotic medication for ≥4 weeks~* Normal hearing by self-report and physical exam~* Use of effective method of birth control for women of childbearing capacity~* Capable to provide informed consent. For patients judged to be incapable to provide informed consent the legal guardian of the patient must agree to participation in the study and provide signed informed consent~Exclusion Criteria:~* Current or past history of substance dependence or abuse (excluding nicotine)~* Other current Axis I disorders~* History of seizure, epilepsy in self or first degree relatives, stoke, brain surgery, head injury, intracranial metal implants, known structural brain lesion, devices that may be affected by tDCS (pacemaker, medication pump, cochlear implant, implanted brain stimulator)~* Frequent and persistent migraines~* History of adverse reaction to neurostimulation~* Participation in study of investigational medication within 6 weeks~* Pregnancy~* Women who are breast-feeding~* Current significant laboratory abnormality

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Active tDCS (Type: EXPERIMENTAL): active tDCS
- control (Type: SHAM_COMPARATOR): sham (placebo) tDCS condition

Based on this trial design, predict the completion outcome and termination type (if applicable).